Lamivudina Aurovitas 300 mg comprimidos recubiertos con película EFG clinical trials

A single-center, self-controlled, single-arm pilot clinical trial to assess the effect of lamivudine (3TC) on neurocognitive impairment biomarkers and type-I IFN (interferon)-stimulated genes in the plasma of patients with Mild Cognitive Impairment (MCI)

This study is looking at a medicine called lamivudine to see if it can help people with Mild Cognitive Impairment, which can be an early sign of Alzheimer's. We want to know if it changes certain markers in the blood and if it's safe to use.